327399009: Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug)

• SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab (medicinal product)\Product containing only trastuzumab (medicinal product)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab (medicinal product)\Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing trastuzumab (medicinal product)\Product containing only trastuzumab (medicinal product)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing trastuzumab (medicinal product)\Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab (medicinal product)\...
• \Product containing only trastuzumab (medicinal product)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product categorised by therapeutic role\Medicinal product acting as antineoplastic agent (product)\...
• \Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab (medicinal product)\...
• \Product containing only trastuzumab (medicinal product)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab (medicinal product)\...
• \Product containing only trastuzumab (medicinal product)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial
• \Product manufactured as parenteral dose form (product)\Product containing trastuzumab in parenteral dose form (medicinal product form)\Trastuzumab only product in parenteral dose form\Trastuzumab 150 mg powder for solution for injection vial

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3690071015	Trastuzumab 150 mg powder for solution for injection vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3690073017	Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start